Related Experiment Video
Updated: Mar 13, 2026

Dynamic Monitoring of Seroconversion using a Multianalyte Immunobead Assay for Covid-19
Published on: February 16, 2022
Lack of harmonisation in immunological data: challenges in synthesising data during the COVID-19 pandemic
Nicole Shaver1, Caroline Colijn2, Jane Heffernan3
1Knowledge Synthesis and Application Unit, School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada.
Insights
The COVID-19 pandemic revealed inconsistencies in human immunology research methods. Standardizing reporting and quality assessment tools is crucial for reliable vaccine immunogenicity studies and future public health responses.
Area of Science:
- Immunology
- Infectious Disease Research
- Public Health
Background:
- The COVID-19 pandemic necessitated rapid development of immune response assays.
- Laboratory practices became heterogeneous due to changing circumstances, impacting data comparability.
- Lack of harmonization hindered cross-study findings, evidence synthesis, and policy guidance.
Purpose of the Study:
- To discuss long-term challenges in standardizing human immunology research highlighted by the pandemic.
- To argue for standardized reporting and quality assessment in vaccine immunogenicity studies.
- To propose practical solutions for laboratory practice comparability while maintaining methodological diversity.
Main Methods:
- Drawing on team experience in synthesizing and modeling vaccine immunogenicity data.
- Analyzing challenges in laboratory harmonization during a public health crisis.
- Developing proposals for standardized tools and practices in immunology research.
Main Results:
- Identified significant heterogeneity in methods, reagents, and reporting across laboratories.
- Demonstrated how this lack of standardization impedes scientific progress and policy application.
- Highlighted the need for proactive implementation of standardization before future crises.
Conclusions:
- Standardization of vaccine immunogenicity studies is essential for robust scientific evidence.
- Practical solutions can enhance comparability without stifling innovation.
- Proactive changes will strengthen future research, reduce waste, and improve public health impact.
Abstract:
The COVID-19 pandemic drove the rapid development of assays to ascertain immune responses, and laboratories were required to adapt to difficult and quickly changing circumstances. While flexibility and innovation were essential, they also introduced heterogeneity in methods, reagents, and reporting practices between labs. This lack of harmonisation made it difficult to compare findings across studies, slowing evidence synthesis, and limiting the usefulness of data for modelling efforts and policy guidance. Drawing on our team's experience synthesising and modelling vaccine immunogenicity data during the pandemic, we discuss the long-term challenges of standardising human immunology research that were highlighted by the COVID-19 pandemic. We argue that vaccine immunogenicity studies require standardised reporting and quality assessment tools. We propose practical solutions to support comparability of laboratory-based practices, while preserving methodological diversity. By implementing changes before the next public health crisis, future research can avoid waste, strengthen certainty, and maximise policy and practice impact.
Related Concept Videos
Immunodeficiency Diseases
There are three main causes of immunodeficiency...
Immunoprecipitation
Chromatin Immunoprecipitation
Chromatin immunoprecipitation, also known as ChIP, is used to study protein-DNA or...

